Cerevel Therapeutics to be Acquired by AbbVie for $8.7 Billion NewsbysupervisorDecember 6, 20231 minute readNo comments
Concerns about the 2024 GOP Presidential Nomination NewsbysupervisorDecember 6, 20232 minute readNo comments
News Chamath Palihapitiya: King of SPACs Chamath Palihapitiya, widely recognized as the poster-child for the SPAC (special purpose acquisition company) phase, made waves in… supervisorAugust 23, 2023 Read More
